Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Russell Kerry Strong Create: Alert

All | News | Filings
Date FiledTypeDescription
07/06/2022 4 Russell Kerry Strong (Chief Medical Officer) has filed a Form 4 on Terns Pharmaceuticals, Inc.
Txns: Granted 240,000 options to buy @ $2.69, valued at $645.6k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy